Derek Logan
1 – 10 of 107
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity
(
- Contribution to journal › Article
-
Mark
A nucleotide-sensing oligomerization mechanism that controls NrdR-dependent transcription of ribonucleotide reductases
(
- Contribution to journal › Article
-
Mark
Dusquetide modulates innate immune response through binding to p62
(
- Contribution to journal › Article
-
Mark
Structural basis of activation and antagonism of receptor signaling mediated by interleukin-27
(
- Contribution to journal › Article
-
Mark
The structure of EXTL3 helps to explain the different roles of bi-domain exostosins in heparan sulfate synthesis
(
- Contribution to journal › Article
- 2021
-
Mark
Entropy–Entropy Compensation between the Protein, Ligand, and Solvent Degrees of Freedom Fine-Tunes Affinity in Ligand Binding to Galectin-3C
(
- Contribution to journal › Article
-
Mark
DutaFabs are engineered therapeutic Fab fragments that can bind two targets simultaneously
(
- Contribution to journal › Article
-
Mark
Exploring ligand dynamics in protein crystal structures with ensemble refinement
(
- Contribution to journal › Article
-
Mark
NAD+ pool depletion as a signal for the Rex regulon involved in Streptococcus agalactiae virulence
(
- Contribution to journal › Article
-
Mark
Solution Structure of the dATP-Inactivated Class I Ribonucleotide Reductase From Leeuwenhoekiella blandensis by SAXS and Cryo-Electron Microscopy
(
- Contribution to journal › Article